학술논문
87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience
Document Type
Abstract
Author
Source
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Subject
Language
ISSN
2590-0188